Boshen Yang

Mr. Boshen Yang


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2025 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
ZYZhenlin Yang
Zhenlin Yang
LHLiangshi Hao
Liangshi Hao
AKAmila Kuati
Amila Kuati
XWXiang Wang
Xiang Wang
ZQZiling Qian
Ziling Qian
YZYuankang Zhu
Yuankang Zhu
Triclosan, a broad-spectrum bactericide in various consumer products, has become a ubiquitous environmental contaminant, with detectable residues found in aquatic systems and human urine. Although studies demonstrated its potential to impair muscle strength, population-level evidence and mechanistic insights linking triclosan exposure to muscle health remain underexplored. This study leveraged 2878 participants data from NHANES, and suggested that individuals in the highest quartile of urinary creatinine-corrected triclosan levels exhibited a 0.18 kg/m2 reduction in appendicular skeletal muscle mass index (ASMI) [β = -0.18, 95 % CI (-0.35, -0.01)] compared to those in the lowest quartile. Importantly, bilirubin was identified as an oxidative stress mediator, explaining 16.799 % of this adverse association. Experimental evidence determined that triclosan accelerates muscle wasting through oxidative imbalance and muscle senescence. Insulin-like growth factor 1 (IGF-1) served as an essential role in the development of triclosan-induced muscle wasting. Molecular docking and molecular dynamics simulations revealed that triclosan could directly interact with IGF-1. The results of experiments demonstrated that triclosan induces muscle senescence and oxidative stress by inhibiting the IGF-1/Akt/mTOR signaling pathway. Furthermore, administration of IGF-1 protein mitigated muscle wasting by reducing oxidative stress and muscle senescence, offering a potential mechanism for counteracting triclosan-induced muscle wasting. This study not only underscores the detrimental effects of triclosan on muscle health but also establishes a mechanistic link between triclosan exposure and muscle wasting. These findings emphasize the need for environmental and public health policies to alleviate the negative effects of triclosan on muscle health.

3 May 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
XWXinyun Wang
Xinyun Wang
YLYangyi Lin
Yangyi Lin
WLWei Liu
Wei Liu
YWYufeng Wu
Yufeng Wu
BYBoshen Yang
Boshen Yang
XJXian Jin
Xian Jin
Background: Emerging evidence has established ferroptosis as a vital factor in the pathogenesis of cardiovascular diseases, especially in septic cardiomyopathy (SCM). Meanwhile, ondansetron (OND), a well-established 5-HT3 receptor antagonist, has gained increasing attention for its pleiotropic effects. However, its potential to modulate ferroptosis in the cardiovascular field remains unexplored. This study aims to fill this gap by exploring the potential of OND as an innovative therapeutic intervention for SCM. Methods: This study utilized both in vitro and in vivo models of septic cardiomyopathy (SCM), which was induced by lipopolysaccharide (LPS) stimulation in neonatal rat cardiomyocytes (NRCMs) and C57BL/6 mice. Through RNA sequencing, as well as molecular and functional assessments—including echocardiography and ferroptosis-related measurements—we revealed the anti-ferroptotic effect of ondansetron (OND). Mechanistically, ATF3 was identified as a pivotal regulator, with its overexpression via AAV9 in vivo and ADV in vitro confirming its role in OND-induced cardioprotection. Results: Ondansetron (OND) showed potent anti-ferroptotic effects in both cellular and murine models of septic cardiomyopathy (SCM). Treatment with OND not only improved cardiac performance but also reduced ferroptotic markers, mitigated lipid peroxidation and iron overload, and bolstered antioxidant defense. Notably, OND administration attenuated oxidative and endoplasmic reticulum (ER) stress while restoring mitochondrial integrity. Mechanistically, the anti-ferroptotic activity of OND was mediated through the HTR3A/ATF3 axis: ATF3 overexpression negated OND’s protective effects, while HTR3A antagonism with VUF10166 recapitulated its benefits. Conversely, HTR3A agonism with PBG attenuated ferroptosis resistance, further implicating this pathway as central to OND’s mechanism. Conclusions: This study demonstrated a novel pharmacological role for ondansetron (OND) in attenuating ferroptosis in septic cardiomyopathy (SCM) via the HTR3A/ATF3 signaling pathway. This finding delineates a novel therapeutic avenue and supports the repurposing of OND beyond its traditional antiemetic use to cardiovascular applications.